{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:51:23Z","timestamp":1790207483305,"version":"4.1.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T00:00:00Z","timestamp":1560816000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1007\/s10554-019-01649-y","type":"journal-article","created":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T08:03:51Z","timestamp":1560845031000},"page":"1945-1954","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Comparison of fractional flow reserve and angiographic characteristics after balloon angioplasty in de novo coronary lesions"],"prefix":"10.1007","volume":"35","author":[{"given":"Ju-Hyun","family":"Chung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Eun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ae-Young","family":"Her","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joo Myung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joon-Hyung","family":"Doh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang-Wook","family":"Nam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bon-Kwon","family":"Koo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9169-6968","authenticated-orcid":false,"given":"Eun-Seok","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,18]]},"reference":[{"key":"1649_CR1","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/s0140-6736(12)61964-3","volume":"381","author":"RA Byrne","year":"2013","unstructured":"Byrne RA, Neumann FJ, Mehilli J et al (2013) Paclitaxel-eluting balloons, paclitaxel-eluting stents, and balloon angioplasty in patients with restenosis after implantation of a drug-eluting stent (ISAR-DESIRE 3): a randomised, open-label trial. Lancet 381:461\u2013467. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(12)61964-3","journal-title":"Lancet"},{"key":"1649_CR2","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1016\/j.jacc.2012.01.015","volume":"59","author":"H Rittger","year":"2012","unstructured":"Rittger H, Brachmann J, Sinha AM et al (2012) A randomized, multicenter, single-blinded trial comparing paclitaxel-coated balloon angioplasty with plain balloon angioplasty in drug-eluting stent restenosis: the PEPCAD-DES study. J Am Coll Cardiol 59:1377\u20131382. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2012.01.015","journal-title":"J Am Coll Cardiol"},{"key":"1649_CR3","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1056\/NEJMoa061254","volume":"355","author":"B Scheller","year":"2006","unstructured":"Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U, Bohm M, Speck U (2006) Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 355:2113\u20132124. \n                    https:\/\/doi.org\/10.1056\/NEJMoa061254","journal-title":"N Engl J Med"},{"key":"1649_CR4","doi-asserted-by":"publisher","first-page":"2986","DOI":"10.1161\/circulationaha.108.839282","volume":"119","author":"M Unverdorben","year":"2009","unstructured":"Unverdorben M, Vallbracht C, Cremers B et al (2009) Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 119:2986\u20132994. \n                    https:\/\/doi.org\/10.1161\/circulationaha.108.839282","journal-title":"Circulation"},{"key":"1649_CR5","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1016\/s0140-6736(18)31719-7","volume":"392","author":"RV Jeger","year":"2018","unstructured":"Jeger RV, Farah A, Ohlow MA et al (2018) Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial. Lancet 392:849\u2013856. \n                    https:\/\/doi.org\/10.1016\/s0140-6736(18)31719-7","journal-title":"Lancet"},{"key":"1649_CR6","doi-asserted-by":"publisher","first-page":"e0147057","DOI":"10.1371\/journal.pone.0147057","volume":"11","author":"SH Ann","year":"2016","unstructured":"Ann SH, Balbir Singh G, Lim KH, Koo BK, Shin ES (2016) Anatomical and physiological changes after paclitaxel-coated balloon for atherosclerotic de novo coronary lesions: Serial IVUS-VH and FFR Study. PLoS ONE 11:e0147057. \n                    https:\/\/doi.org\/10.1371\/journal.pone.0147057","journal-title":"PLoS ONE"},{"key":"1649_CR7","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.1016\/j.rec.2016.03.026","volume":"69","author":"SH Ann","year":"2016","unstructured":"Ann SH, Her AY, Singh GB, Okamura T, Koo BK, Shin ES (2016) Serial morphological and functional assessment of the paclitaxel-coated balloon for de novo lesions. Rev Esp Cardiol 69:1026\u20131032. \n                    https:\/\/doi.org\/10.1016\/j.rec.2016.03.026","journal-title":"Rev Esp Cardiol"},{"key":"1649_CR8","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s10554-018-1351-z","volume":"34","author":"AY Her","year":"2018","unstructured":"Her AY, Shin ES, Lee JM, Garg S, Doh JH, Nam CW, Koo BK (2018) Paclitaxel-coated balloon treatment for functionally nonsignificant residual coronary lesions after balloon angioplasty. Int J Cardiovasc Imaging 34:1339\u20131347. \n                    https:\/\/doi.org\/10.1007\/s10554-018-1351-z","journal-title":"Int J Cardiovasc Imaging"},{"key":"1649_CR9","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1002\/ccd.26257","volume":"88","author":"ES Shin","year":"2016","unstructured":"Shin ES, Ann SH, Balbir Singh G, Lim KH, Kleber FX, Koo BK (2016) Fractional flow reserve-guided paclitaxel-coated balloon treatment for de novo coronary lesions. Catheter Cardiovasc Interv 88:193\u2013200. \n                    https:\/\/doi.org\/10.1002\/ccd.26257","journal-title":"Catheter Cardiovasc Interv"},{"key":"1649_CR10","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s00392-013-0609-7","volume":"102","author":"FX Kleber","year":"2013","unstructured":"Kleber FX, Rittger H, Bonaventura K et al (2013) Drug-coated balloons for treatment of coronary artery disease: updated recommendations from a consensus group. Clin Res Cardiol 102:785\u2013797. \n                    https:\/\/doi.org\/10.1007\/s00392-013-0609-7","journal-title":"Clin Res Cardiol"},{"key":"1649_CR11","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/0002-9149(91)90780-o","volume":"68","author":"MS Huber","year":"1991","unstructured":"Huber MS, Mooney JF, Madison J, Mooney MR (1991) Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 68:467\u2013471. \n                    https:\/\/doi.org\/10.1016\/0002-9149(91)90780-o","journal-title":"Am J Cardiol"},{"key":"1649_CR12","first-page":"493","volume":"16","author":"JH Rogers","year":"2004","unstructured":"Rogers JH, Lasala JM (2004) Coronary artery dissection and perforation complicating percutaneous coronary intervention. J Invasive Cardiol 16:493\u2013499","journal-title":"J Invasive Cardiol"},{"key":"1649_CR13","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1093\/eurheartj\/eht040","volume":"34","author":"HJ Jang","year":"2013","unstructured":"Jang HJ, Koo BK, Lee HS et al (2013) Safety and efficacy of a novel hyperaemic agent, intracoronary nicorandil, for invasive physiological assessments in the cardiac catheterization laboratory. Eur Heart J 34:2055\u20132062. \n                    https:\/\/doi.org\/10.1093\/eurheartj\/eht040","journal-title":"Eur Heart J"},{"key":"1649_CR14","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1161\/01.CIR.99.7.883","volume":"99","author":"GJ Bech","year":"1999","unstructured":"Bech GJ, Pijls NH, De Bruyne B, Peels KH, Michels HR, Bonnier HJ, Koolen JJ (1999) Usefulness of fractional flow reserve to predict clinical outcome after balloon angioplasty. Circulation 99:883\u2013888","journal-title":"Circulation"},{"key":"1649_CR15","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1161\/01.CIR.73.6.1223","volume":"73","author":"HV Anderson","year":"1986","unstructured":"Anderson HV, Roubin GS, Leimgruber PP, Cox WR, Douglas JS Jr, King SB 3rd, Gruentzig AR (1986) Measurement of transstenotic pressure gradient during percutaneous transluminal coronary angioplasty. Circulation 73:1223\u20131230","journal-title":"Circulation"},{"key":"1649_CR16","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1056\/NEJMoa1205361","volume":"367","author":"B De Bruyne","year":"2012","unstructured":"De Bruyne B, Pijls NH, Kalesan B et al (2012) Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 367:991\u20131001. \n                    https:\/\/doi.org\/10.1056\/NEJMoa1205361","journal-title":"N Engl J Med"},{"key":"1649_CR17","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1016\/j.jcin.2012.07.007","volume":"5","author":"SJ Park","year":"2012","unstructured":"Park SJ, Kang SJ, Ahn JM et al (2012) Visual-functional mismatch between coronary angiography and fractional flow reserve. JACC Cardiovasc Interv 5:1029\u20131036. \n                    https:\/\/doi.org\/10.1016\/j.jcin.2012.07.007","journal-title":"JACC Cardiovasc Interv"},{"key":"1649_CR18","doi-asserted-by":"publisher","first-page":"1548","DOI":"10.1016\/j.jcin.2016.04.008","volume":"9","author":"HY Kim","year":"2016","unstructured":"Kim HY, Lim HS, Doh JH et al (2016) Physiological severity of coronary artery stenosis depends on the amount of myocardial mass subtended by the coronary artery. JACC Cardiovasc Interv 9:1548\u20131560. \n                    https:\/\/doi.org\/10.1016\/j.jcin.2016.04.008","journal-title":"JACC Cardiovasc Interv"},{"key":"1649_CR19","doi-asserted-by":"publisher","first-page":"2928","DOI":"10.1161\/01.CIR.103.24.2928","volume":"103","author":"GJ Bech","year":"2001","unstructured":"Bech GJ, De Bruyne B, Pijls NH et al (2001) Fractional flow reserve to determine the appropriateness of angioplasty in moderate coronary stenosis: a randomized trial. Circulation 103:2928\u20132934","journal-title":"Circulation"},{"key":"1649_CR20","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1016\/j.jacc.2005.04.041","volume":"46","author":"A Berger","year":"2005","unstructured":"Berger A, Botman KJ, MacCarthy PA, Wijns W, Bartunek J, Heyndrickx GR, Pijls NH, De Bruyne B (2005) Long-term clinical outcome after fractional flow reserve-guided percutaneous coronary intervention in patients with multivessel disease. J Am Coll Cardiol 46:438\u2013442. \n                    https:\/\/doi.org\/10.1016\/j.jacc.2005.04.041","journal-title":"J Am Coll Cardiol"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10554-019-01649-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-019-01649-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T23:12:29Z","timestamp":1592349149000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10554-019-01649-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,18]]},"references-count":20,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["1649"],"URL":"https:\/\/doi.org\/10.1007\/s10554-019-01649-y","relation":{},"ISSN":["1569-5794","1573-0743"],"issn-type":[{"value":"1569-5794","type":"print"},{"value":"1573-0743","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,18]]},"assertion":[{"value":"25 January 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}